From: OC EXECSEC
Sent: Thursday, September 25, 2003 11:42 AM
To: Dockets, FDA
Subject: Counterfeit drugs -- Docket No. 03N-0361. 



-----Original Message-----
From: Crim, Carol H 
Sent: Wednesday, August 06, 2003 3:01 PM
To: OC EXECSEC
Subject: FW: Counterfeit and gray market drugs




-----Original Message-----
From: McClellan, Mark, M.D. 
Sent: Tuesday, August 05, 2003 9:43 PM
To: Hubbard, William K; Crim, Carol H
Subject: FW: Counterfeit and gray market drugs


another interested party

-----Original Message-----
From: Garry Whyte [mailto:garry@centurytel.net]
Sent: Tuesday, August 05, 2003 7:21 PM
To: 'Mark McClellan MD'
Subject: Counterfeit and gray market drugs


Commissioner Mark McClellan MD
DHHS/FDA/OC/IO
mmcclellan@oc.fda.gov

Dear Commissioner McClellan,

We have developed a method of coding that authenticates objects.  It was
originally developed for aircraft parts, and it has been experimentally
applied to apparel, grains and even bullets (de facto bullet
registration is apolitical.)

We have been talking with people at Glaxo about the possibility of
marking their AIDS medication headed out to Africa so that the
caregivers in the field could have some means of assuring themselves
that they were administering real Glaxo products.  On the basis of that
work we are entrants in the current Rolex Entrepreneurship Awards and
have asked that the prize monies all be applied to increasing Internet
connectivity for African healthcare workers and organizations.

I have read about your anti-counterfeiting Task Force and that they will
be receiving testimony over the next sixty days.  Is there any
possibility I could speak to them to see if what we're doing might
represent a general solution to pharmaceutical counterfeiting?

My thanks for your help and for the work that you are already doing.

Regards,

Garry Whyte
President
Congruence LLC
garry@congruencellc.com
(503)678-5750